Brain natriuretic peptide (BNP) acts as a protective signal between the heart and kidneys, counteracting the RAAS hormonal system that drives both heart failure and kidney disease.
Dual-organ protectionBNP counteracts the RAAS system to protect both the heart and kidneys, with the kidneys themselves signaling the heart to produce more BNP
What the researchers found
BNP (brain natriuretic peptide) plays a protective role in both the heart and kidneys, functioning as a key mediator of the heart-kidney connection. The review reveals that BNP levels are elevated in chronic kidney disease patients even without heart disease — a finding whose mechanism had been unclear. Evidence suggests the kidney's renal medulla produces depressor substances, and extracts from kidney papillary tips can actually stimulate cardiomyocytes (heart muscle cells) to produce and secrete more BNP.
BNP appears to counteract the renin-angiotensin-aldosterone system (RAAS) — the hormonal system that raises blood pressure and promotes fluid retention — providing a natural protective mechanism against both heart failure and kidney disease progression.
Why it matters
Heart failure and kidney disease frequently occur together, creating a vicious cycle that accelerates both conditions. Understanding that BNP serves as a two-way protective signal between these organs helps explain why natriuretic peptide-based therapies (like sacubitril/valsartan) benefit both the heart and kidneys simultaneously. This knowledge is driving the development of treatments that harness the body's own peptide defense system.
The numbers in context
Review article — synthesizes evidence on BNP's role in heart-kidney crosstalk
How the study worked
This is a narrative review examining the molecular mechanisms of BNP in heart-kidney interactions. The authors synthesized evidence from basic science and clinical studies, focusing on BNP's relationship with the RAAS system, its expression patterns in cardiac and renal tissue, and the signaling pathways involved in its protective effects.
Who was studied
Review of basic science and clinical evidence in heart failure and chronic kidney disease patients
What this study cannot tell us
As a narrative review rather than a systematic review, the evidence selection may not be comprehensive. The mechanism by which kidney extracts stimulate cardiac BNP production is described but not fully characterized. The review does not provide clinical trial data on BNP-targeted therapies.
How to read the evidence
This is a narrative review synthesizing existing evidence on BNP's role in heart-kidney crosstalk. It provides a useful conceptual framework but does not present new data or follow systematic review methodology.
When this study was published
Published in 2019, this review is relatively recent and reflects understanding that has been further validated by clinical outcomes data from neprilysin inhibitor trials (which boost BNP levels).
The bigger picture
BNP has evolved from a simple diagnostic blood test into a recognized therapeutic target. The drug sacubitril/valsartan (Entresto) works by preventing BNP breakdown, allowing higher levels to exert their protective effects. This review provides the mechanistic framework for why boosting natriuretic peptide signaling benefits both the heart and kidneys — a concept that's reshaping how cardiorenal syndrome is treated.
Questions still open
- What specific substances does the kidney's renal medulla release to stimulate cardiac BNP production?
- Could synthetic BNP analogs be developed as targeted therapies for cardiorenal syndrome?
- Do individual genetic variations in BNP production explain why some patients are more resilient to combined heart-kidney disease?
Common questions
Why are BNP levels high in kidney disease patients who don't have heart failure?
How does BNP protect the heart and kidneys?
Read the original research
BNP as a Major Player in the Heart-Kidney Connection.
International journal of molecular sciences, 20(14)
Citation
Okamoto, Ryuji; Ali, Yusuf; Hashizume, Ryotaro; Suzuki, Noboru; Ito, Masaaki. (2019). BNP as a Major Player in the Heart-Kidney Connection.. International journal of molecular sciences, 20(14). https://doi.org/10.3390/ijms20143581